Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Bladder Cancer, January 2018

Free Subscription


Abstracts

Retrieve all available abstracts of the following 320 articles:
HTML format


 

Single Articles

  1. PENG F, Li H, Xiao H, Li L, et al
    Identification of a three miRNA signature as a novel potential prognostic biomarker in patients with bladder cancer.
    Oncotarget. 2017;8:105553-105560.
    Abstract     Related articles   

  2. HO JN, Kang M, Lee S, Oh JJ, et al
    Anticancer effect of S-allyl-L-cysteine via induction of apoptosis in human bladder cancer cells.
    Oncol Lett. 2018;15:623-629.
    Abstract     Related articles   

  3. SELINSKI S
    Discovering urinary bladder cancer risk variants: Status quo after almost ten years of genome-wide association studies.
    EXCLI J. 2017;16:1288-1296.
    Abstract     Related articles   

  4. SUNDAHL N, Rottey S, De Maeseneer D, Ost P, et al
    Pembrolizumab for the treatment of bladder cancer.
    Expert Rev Anticancer Ther. 2017 Dec 29:1-8. doi: 10.1080/14737140.2018.1421461.
    Abstract     Related articles   

  5. AFSHARMOGHADAM N, Haghighatian Z, Mazdak H, Mirkheshti N, et al
    Concentration- Dependent Effects of Curcumin on 5-Fluorouracil Efficacy in Bladder Cancer Cells
    Asian Pac J Cancer Prev. 2017;18:3225-3230.
    Abstract     Related articles   

  6. NEOH CA, Wu WT, Dai GF, Su JH, et al
    Flaccidoxide-13-Acetate Extracted from the Soft Coral Cladiella kashmani Reduces Human Bladder Cancer Cell Migration and Invasion through Reducing Activation of the FAK/PI3K/AKT/mTOR Signaling Pathway.
    Molecules. 2017;23.
    Abstract     Related articles   

  7. GUERCIO V, Turati F, Bosetti C, Polesel J, et al
    Bladder cancer risk in users of selected drugs for cardiovascular disease prevention.
    Eur J Cancer Prev. 2017 Dec 26. doi: 10.1097/CEJ.0000000000000419.
    Abstract     Related articles   

  8. ZHANG Q, Wang W, Xu W, DU M, et al
    Genetic Variations in the 3'-untranslated Regions of Genes Involved in the Cell Cycle and Apoptosis Pathways Affect Bladder Cancer Risk.
    Cancer Genomics Proteomics. 2018;15:67-72.
    Abstract     Related articles   

  9. SIRACUSANO S, D'Elia C, Cerruto MA, Saleh O, et al
    Quality of Life in Patients with Bladder Cancer Undergoing Ileal Conduit: A Comparison of Women Versus Men.
    In Vivo. 2018;32:139-143.
    Abstract     Related articles   

  10. LEE YH, Yeh CH
    Laminar shear stress inhibits high glucose-induced migration and invasion in human bladder cancer cells.
    In Vitro Cell Dev Biol Anim. 2017 Dec 22. pii: 10.1007/s11626-017-0217.
    Abstract     Related articles   

  11. SUSSMAN RD, Han CJ, Marchalik D, Carvahlo FL, et al
    To oophorectomy or not to oophorectomy: Practice patterns among urologists treating bladder cancer.
    Urol Oncol. 2017 Dec 19. pii: S1078-1439(17)30606.
    Abstract     Related articles   

  12. JUNG YL, Tompa E, Longo C, Kalcevich C, et al
    The Economic Burden of Bladder Cancer due to Occupational Exposure.
    J Occup Environ Med. 2017 Dec 21. doi: 10.1097/JOM.0000000000001242.
    Abstract     Related articles   

  13. LI B, Xie F, Zheng FX, Jiang GS, et al
    Overexpression of CircRNA BCRC4 regulates cell apoptosis and MicroRNA-101/EZH2 signaling in bladder cancer.
    J Huazhong Univ Sci Technolog Med Sci. 2017;37:886-890.
    Abstract     Related articles   

  14. PRICE L, Glynn P, Zarkar A
    Interstitial lung disease secondary to Cetuximab in bladder cancer: an Oncologist's perspective.
    BMJ Case Rep. 2017;2017.
    Abstract     Related articles   

  15. PAVANELLO S, Carta A, Mastrangelo G, Campisi M, et al
    Relationship between Telomere Length, Genetic Traits and Environmental/Occupational Exposures in Bladder Cancer Risk by Structural Equation Modelling.
    Int J Environ Res Public Health. 2017;15.
    Abstract     Related articles   

  16. SAADI A, Bouzouita A, Rebai MH, Cherif M, et al
    Superselective embolisation of bilateral superior vesical arteries for management of intractable hematuria in context of metastatic bladder cancer.
    Asian J Urol. 2017;4:131-134.
    Abstract     Related articles   

  17. OKHOLM TLH, Nielsen MM, Hamilton MP, Christensen LL, et al
    Circular RNA expression is abundant and correlated to aggressiveness in early-stage bladder cancer.
    NPJ Genom Med. 2017;2:36.
    Abstract     Related articles   

  18. LIU D, Abbosh P, Keliher D, Reardon B, et al
    Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer.
    Nat Commun. 2017;8:2193.
    Abstract     Related articles   

  19. DHAINI HR, El Hafi B, Khamis AM
    NAT1 genotypic and phenotypic contribution to urinary bladder cancer risk: a systematic review and meta-analysis.
    Drug Metab Rev. 2017 Dec 19:1-12. doi: 10.1080/03602532.2017.1415928.
    Abstract     Related articles   

  20. KANDEMIRLI SG, Dikici AS, Nurili F, Tutar O, et al
    Bladder cancer in an inguinal vesical hernia.
    J Med Ultrason (2001). 2017 Dec 18. pii: 10.1007/s10396-017-0854.
    Abstract     Related articles   

  21. HURST CD, Knowles MA
    Bladder cancer: Multi-omic profiling refines the molecular view.
    Nat Rev Clin Oncol. 2017 Dec 19. pii: nrclinonc.2017.
    Abstract     Related articles   

  22. MATSUMOTO K, Tabata KI, Hirayama T, Shimura S, et al
    Robot-assisted laparoscopic radical cystectomy is a safe and effective procedure for patients with bladder cancer compared to laparoscopic and open surgery: Perioperative outcomes of a single-center experience.
    Asian J Surg. 2017 Dec 15. pii: S1015-9584(17)30518.
    Abstract     Related articles   

  23. BOOTH CM, Karim S, Brennan K, Siemens DR, et al
    Perioperative chemotherapy for bladder cancer in the general population: Are practice patterns finally changing?
    Urol Oncol. 2017 Dec 15. pii: S1078-1439(17)30603.
    Abstract     Related articles   

  24. XU X, Li J, Zhu Y, Xie B, et al
    CRISPR-ON-Mediated KLF4 overexpression inhibits the proliferation, migration and invasion of urothelial bladder cancer in vitro and in vivo.
    Oncotarget. 2017;8:102078-102087.
    Abstract     Related articles   

  25. KLITON J, Polgar C, Tenke P, Kovacs G, et al
    [Image-guided radiotherapy for muscle invasive bladder cancer with intravesical lipiodol injection. A new option for bladder sparing treatment].
    Orv Hetil. 2017;158:2041-2047.
    Abstract     Related articles   

  26. CIAMPORCERO E, Daga M, Pizzimenti S, Roetto A, et al
    Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer.
    Free Radic Biol Med. 2017 Dec 14. pii: S0891-5849(17)31237.
    Abstract     Related articles   

  27. WANG Z, Que H, Suo C, Han Z, et al
    Evaluation of the NMP22 BladderChek test for detecting bladder cancer: a systematic review and meta-analysis.
    Oncotarget. 2017;8:100648-100656.
    Abstract     Related articles   

  28. KO K, Jeong CW, Kwak C, Kim HH, et al
    Significance of Ki-67 in non-muscle invasive bladder cancer patients: a systematic review and meta-analysis.
    Oncotarget. 2017;8:100614-100630.
    Abstract     Related articles   

  29. CHAN OTM, Furuya H, Pagano I, Shimizu Y, et al
    Association of MMP-2, RB and PAI-1 with decreased recurrence-free survival and overall survival in bladder cancer patients.
    Oncotarget. 2017;8:99707-99721.
    Abstract     Related articles   

  30. XIAOQIANG L, Xuerong Z, Juan L, Mathew BS, et al
    Efficacy of pudendal nerve block for alleviation of catheter-related bladder discomfort in male patients undergoing lower urinary tract surgeries: A randomized, controlled, double-blind trial.
    Medicine (Baltimore). 2017;96:e8932.
    Abstract     Related articles   

  31. TOUZANI MA, Yddoussalah O
    [Cavernous metastasis from blader tumor].
    Pan Afr Med J. 2017;28:60.
    Abstract     Related articles   

  32. SAXE JS
    Denial.
    Ann Intern Med. 2017;167:828-829.
    Abstract     Related articles   

  33. DAVIDSSON S, Andren O, Ohlson AL, Carlsson J, et al
    FOXP3+ regulatory T cells in normal prostate tissue, postatrophic hyperplasia, prostatic intraepithelial neoplasia, and tumor histological lesions in men with and without prostate cancer.
    Prostate. 2017 Nov 6. doi: 10.1002/pros.23442.
    Abstract     Related articles   

  34. INOUE A, Maeda S, Kinoshita R, Tsuboi M, et al
    Density of tumor-infiltrating granzyme B-positive cells predicts favorable prognosis in dogs with transitional cell carcinoma.
    Vet Immunol Immunopathol. 2017;190:53-56.
    Abstract     Related articles   

  35. CHARGARI C, Martelli H, Guerin F, Bacorro W, et al
    Pulsed-dose rate brachytherapy for pediatric bladder prostate rhabdomyosarcoma: Compliance and early clinical results.
    Radiother Oncol. 2017;124:285-290.
    Abstract     Related articles   

  36. INAMURA K, Kobayashi M, Nagano H, Sugiura Y, et al
    A novel fusion of HNRNPA1-ALK in inflammatory myofibroblastic tumor of urinary bladder.
    Hum Pathol. 2017;69:96-100.
    Abstract     Related articles   

  37. DIETRICH F, Figueiro F, Filippi-Chiela EC, Cappellari AR, et al
    Ecto-5'-nucleotidase/CD73 contributes to the radiosensitivity of T24 human bladder cancer cell line.
    J Cancer Res Clin Oncol. 2018 Jan 5. pii: 10.1007/s00432-017-2567.
    Abstract     Related articles   

  38. YU Z, Yue W, Jiuzhi L, Youtao J, et al
    The risk of bladder cancer in patients with urinary calculi: a meta-analysis.
    Urolithiasis. 2018 Jan 5. pii: 10.1007/s00240-017-1033.
    Abstract     Related articles   

  39. WU S, Ye J, Wang Z, Lin SX, et al
    Expression of aromatase in tumor related stroma is associated with human bladder cancer progression.
    Cancer Biol Ther. 2018 Jan 5:0. doi: 10.1080/15384047.2017.1414762.
    Abstract     Related articles   

  40. COLLINS SD, Leech MM
    A review of plan library approaches in adaptive radiotherapy of bladder cancer.
    Acta Oncol. 2018 Jan 4:1-8. doi: 10.1080/0284186X.2017.1420908.
    Abstract     Related articles   

  41. ROSAS S, Sabeh K, Kurowicki J, Buller L, et al
    National use of total hip arthroplasty among patients with a history of breast, lung, prostate, colon or bladder cancer-an analysis of the Medicare population.
    Ann Transl Med. 2017;5.
    Abstract     Related articles   

  42. SEGOVIA C, Paramio JM
    Ezh2-dependent therapies in bladder cancer: synthetic lethality.
    Ann Transl Med. 2017;5:494.
    Abstract     Related articles   

  43. JUENGEL E, Najafi R, Rutz J, Maxeiner S, et al
    HDAC inhibition as a treatment concept to combat temsirolimus-resistant bladder cancer cells.
    Oncotarget. 2017;8:110016-110028.
    Abstract     Related articles   

  44. LIAO XZ, Tao LT, Liu JH, Gu YY, et al
    Matrine combined with cisplatin synergistically inhibited urothelial bladder cancer cells via down-regulating VEGF/PI3K/Akt signaling pathway.
    Cancer Cell Int. 2017;17:124.
    Abstract     Related articles   

  45. ZHANG L, Xu J, Yang G, Li H, et al
    miR-202 inhibits cell proliferation, migration, and invasion by targeting EGFR in human bladder cancer.
    Oncol Res. 2018 Jan 3. doi: 10.3727/096504018X15149787144385.
    Abstract     Related articles   

  46. THOMA C
    Bladder cancer: IMvigor211 trial outcomes reported.
    Nat Rev Urol. 2018 Jan 3. pii: nrurol.2017.225. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  47. THOMA C
    Bladder cancer: Chemotherapy and checkpoint blockade.
    Nat Rev Urol. 2018 Jan 3. pii: nrurol.2017.224. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  48. THOMA C
    Bladder cancer: Activity and safety of avelumab in JAVELIN.
    Nat Rev Urol. 2018 Jan 3. pii: nrurol.2017.227. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  49. ZUIVERLOON TCM, de Jong FC, Theodorescu D
    Clinical Decision Making in Surveillance of Non-Muscle-Invasive Bladder Cancer: The Evolving Roles of Urinary Cytology and Molecular Markers.
    Oncology (Williston Park). 2017;31.
    Abstract     Related articles   

  50. KIM SJ, Koo PJ, Pak K, Kim IJ, et al
    Diagnostic accuracy of C-11 choline and C-11 acetate for lymph node staging in patients with bladder cancer: a systematic review and meta-analysis.
    World J Urol. 2018 Jan 2. pii: 10.1007/s00345-017-2168.
    Abstract     Related articles   

  51. HARSHMAN LC, Tripathi A, Kaag M, Efstathiou JA, et al
    Contemporary Patterns of Multidisciplinary Care in Patients With Muscle-invasive Bladder Cancer.
    Clin Genitourin Cancer. 2017 Dec 6. pii: S1558-7673(17)30364.
    Abstract     Related articles   

  52. ROSE TL, Lotan Y
    Advancements in optical techniques and imaging in the diagnosis and management of bladder cancer.
    Urol Oncol. 2017 Dec 26. pii: S1078-1439(17)30602.
    Abstract     Related articles   

  53. YOSHIDA T, Kates M, Sopko NA, Liu X, et al
    Ex vivo culture of tumor cells from N-methyl-N-nitrosourea-induced bladder cancer in rats: Development of organoids and an immortalized cell line.
    Urol Oncol. 2017 Dec 26. pii: S1078-1439(17)30618.
    Abstract     Related articles   

  54. ALJABERY F, Olsson H, Gimm O, Jahnson S, et al
    M2-macrophage infiltration and macrophage traits of tumor cells in urinary bladder cancer.
    Urol Oncol. 2017 Dec 26. pii: S1078-1439(17)30608.
    Abstract     Related articles   

  55. OSTERMAN CK, Alanzi J, Lewis JD, Kaufman EL, et al
    Association Between Symptomatic Versus Asymptomatic Recurrence and Survival in Bladder Cancer.
    Clin Genitourin Cancer. 2017 Dec 6. pii: S1558-7673(17)30361.
    Abstract     Related articles   

  56. NKWAM N, Trecarten S, Momcilovic S, Bazo AE, et al
    Isolated red patches seen during endoscopic surveillance of bladder cancer - when should we biopsy?
    J Endourol. 2017 Dec 29. doi: 10.1089/end.2017.0744.
    Abstract     Related articles   

  57. GOLABEK T, Socha K, Kudelski J, Darewicz B, et al
    Chromium in urothelial carcinoma of the bladder.
    Ann Agric Environ Med. 2017;24:602-605.
    Abstract     Related articles   

  58. HEIN DW, Zhang X, Doll MA
    Role of N-acetyltransferase 2 acetylation polymorphism in 4, 4'-methylene bis (2-chloroaniline) biotransformation.
    Toxicol Lett. 2018;283:100-105.
    Abstract     Related articles   

  59. ARIAS-STELLA JA 3RD, Shah AB, Gupta NS, Williamson SR, et al
    CK20 and p53 Immunohistochemical Staining Patterns in Urinary Bladder Specimens With Equivocal Atypia.
    Arch Pathol Lab Med. 2018;142:64-69.
    Abstract     Related articles   

  60. YANG G, Wang Z, Liu S, Wu F, et al
    A Rare Case of Urachal Carcinoma Metastatic to Thoracic Vertebra Detected by FDG PET/CT.
    Clin Nucl Med. 2017 May 5. doi: 10.1097/RLU.0000000000001680.
    Abstract     Related articles   

  61. ROY SG, Parida GK, Tripathy S, Singhal A, et al
    In Vivo Demonstration of PSMA Expression in Adenocarcinoma Urinary Bladder Using 68Ga-PSMA 11 PET/CT.
    Clin Nucl Med. 2017 May 6. doi: 10.1097/RLU.0000000000001683.
    Abstract     Related articles   

  62. YANG AW, Pooli A, Lele SM, Kim IW, et al
    Lymphoepithelioma-like, a variant of urothelial carcinoma of the urinary bladder: a case report and systematic review for optimal treatment modality for disease-free survival.
    BMC Urol. 2017;17:34.
    Abstract     Related articles   

  63. TAN WS, Lamb BW, Sridhar A, Briggs TP, et al
    A comprehensive guide to perioperative management and operative technique for robotic cystectomy with intracorporeal urinary diversion.
    Urologia. 2017;84:71-78.
    Abstract     Related articles   

  64. CHANG E, Sabichi AL, Sada YH
    Myasthenia Gravis After Nivolumab Therapy for Squamous Cell Carcinoma of the Bladder.
    J Immunother. 2017;40:114-116.
    Abstract     Related articles   

  65. LIZEE D, Salas RS, Barret E, Galiano M, et al
    Impact of neoadjuvant chemotherapy on complications of minimally invasive radical cystectomy.
    Actas Urol Esp. 2017;41:88-96.
    Abstract     Related articles   

  66. KANASHIRO A, Gaya JM, Palou J, Gausa L, et al
    Robot-assisted radical cystoprostatectomy: Analysis of the complications and oncological and functional aspects.
    Actas Urol Esp. 2017;41:267-273.
    Abstract     Related articles   

  67. LIU J, Bi J, Li Z, Li Z, et al
    miR214 reduces cisplatin resistance by targeting netrin1 in bladder cancer cells.
    Int J Mol Med. 2018 Jan 10. doi: 10.3892/ijmm.2018.3374.
    Abstract     Related articles   

  68. GLEICHENHAGEN J, Arndt C, Casjens S, Meinig C, et al
    Evaluation of a New Survivin ELISA and UBC((R)) Rapid for the Detection of Bladder Cancer in Urine.
    Int J Mol Sci. 2018;19.
    Abstract     Related articles   

  69. BAKER SC, Arlt VM, Indra R, Joel M, et al
    Differentiation-associated urothelial cytochrome P450 oxidoreductase predicates the xenobiotic-metabolising activity of "luminal" muscle-invasive bladder cancers.
    Mol Carcinog. 2018 Jan 11. doi: 10.1002/mc.22784.
    Abstract     Related articles   

  70. POLETAJEW S, Biernacki R, Buraczynski P, Chojnacki J, et al
    Predictors and prognostic implications of clinical decisions in patients with primary high-risk non-muscle-invasive bladder cancer - results of a cross country retrospective study.
    Neoplasma. 2018;65:147-152.
    Abstract     Related articles   

  71. GAO L, Yan P, Guo FF, Liu HJ, et al
    MiR-1-3p inhibits cell proliferation and invasion by regulating BDNF-TrkB signaling pathway in bladder cancer.
    Neoplasma. 2018;65:89-96.
    Abstract     Related articles   

  72. WANG B, Wan F, Sheng H, Zhu Y, et al
    Identification and validation of an 18-gene signature highly-predictive of bladder cancer metastasis.
    Sci Rep. 2018;8:374.
    Abstract     Related articles   

  73. GUO P, Zhang G, Meng J, He Q, et al
    Upregulation of long non-coding RNA TUG1 promotes bladder cancer cell 5 proliferation, migration and invasion by inhibiting miR-29c.
    Oncol Res. 2018 Jan 10. doi: 10.3727/096504018X15152085755247.
    Abstract     Related articles   

  74. ZHAI X, Xu W
    Long noncoding RNA ATB promotes proliferation, migration and invasion in bladder cancer by suppressing microRNA-126.
    Oncol Res. 2018 Jan 10. doi: 10.3727/096504018X15152072098476.
    Abstract     Related articles   

  75. WALKER M, Doiron RC, French SD, Feldman-Stewart D, et al
    Perioperative chemotherapy for bladder cancer: A qualitative study of physician knowledge, attitudes, and behaviour.
    Can Urol Assoc J. 2017 Dec 22. pii: cuaj.4791. doi: 10.5489/cuaj.4791.
    Abstract     Related articles   

  76. YOO CH
    The Author's Response: Bioinformatics Analysis in Downstream Genes of the mTOR Pathway to Predict Recurrence and Progression of Bladder Cancer.
    J Korean Med Sci. 2018;33:e32.
    Abstract     Related articles   

  77. LI C, Liu H, Xu Y
    Letter to the Editor: Bioinformatics Analysis in Downstream Genes of the mTOR Pathway to Predict Recurrence and Progression of Bladder Cancer.
    J Korean Med Sci. 2018;33:e31.
    Abstract     Related articles   

  78. LONG Q, Lin TY, Huang Y, Li X, et al
    Imaging-guided photo-therapeutic nanoporphyrin synergized HSP90 inhibitor in patient-derived xenograft bladder cancer model.
    Nanomedicine. 2018 Jan 6. pii: S1549-9634(17)30592.
    Abstract     Related articles   

  79. WANG F, Tang J, Li P, Si S, et al
    Chloroquine Enhances the Radiosensitivity of Bladder Cancer Cells by Inhibiting Autophagy and Activating Apoptosis.
    Cell Physiol Biochem. 2017;45:54-66.
    Abstract     Related articles   

  80. SALEM J, Paffenholz P, Bolenz C, von Brandenstein M, et al
    Websites on Bladder Cancer: an Appropriate Source of Patient Information?
    J Cancer Educ. 2018 Jan 8. pii: 10.1007/s13187-017-1316.
    Abstract     Related articles   

  81. VAN DER POL CB, Shinagare AB, Tirumani SH, Preston MA, et al
    Bladder cancer local staging: multiparametric MRI performance following transurethral resection.
    Abdom Radiol (NY). 2018 Jan 9. pii: 10.1007/s00261-017-1449.
    Abstract     Related articles   

  82. ZHANG L, Yang G, Chen H, Huang Y, et al
    Depletion of astrocyte elevated gene-1 suppresses tumorigenesis through inhibition of Akt activity in bladder cancer cells.
    Am J Transl Res. 2017;9:5422-5431.
    Abstract     Related articles   

  83. SAAD FT, Hincal E, Kaymakamzade B
    Dynamics of Immune Checkpoints, Immune System, and BCG in the Treatment of Superficial Bladder Cancer.
    Comput Math Methods Med. 2017;2017:3573082.
    Abstract     Related articles   

  84. GHATE K, Brennan K, Karim S, Siemens DR, et al
    Concurrent chemoradiotherapy for bladder cancer: Practice patterns and outcomes in the general population.
    Radiother Oncol. 2018 Jan 3. pii: S0167-8140(17)32764.
    Abstract     Related articles   

  85. COSTA-MARTINEZ MA, Prieto Vita M, Garces Proano LE, Carro Rubias C, et al
    [Neurofibromas in the urogenital system: Report of two cases and literature review.]
    Arch Esp Urol. 2017;70:796-799.
    Abstract     Related articles   

  86. JING Y, Zhang R, Ma P, Cai MC, et al
    Prevalence and clonality of synchronous primary carcinomas in the bladder and prostate.
    J Pathol. 2018;244:5-10.
    Abstract     Related articles   

  87. YU SS, Ballas LK, Skinner EC, Dorff TB, et al
    Immunotherapy in urothelial cancer, part 2: adjuvant, neoadjuvant, and adjunctive treatment.
    Clin Adv Hematol Oncol. 2017;15:543-551.
    Abstract     Related articles   

  88. PFARR N, Darb-Esfahani S, Leichsenring J, Taube E, et al
    Mutational profiles of Brenner tumors show distinctive features uncoupling urothelial carcinomas and ovarian carcinoma with transitional cell histology.
    Genes Chromosomes Cancer. 2017;56:758-766.
    Abstract     Related articles   

  89. NGUYEN VP, Park S, Oh J, Wook Kang H, et al
    Biocompatible astaxanthin as novel contrast agent for biomedical imaging.
    J Biophotonics. 2017;10:1053-1061.
    Abstract     Related articles   

  90. MAO XW, Xiao JQ, Li ZY, Zheng YC, et al
    Effects of microRNA-135a on the epithelial-mesenchymal transition, migration and invasion of bladder cancer cells by targeting GSK3beta through the Wnt/beta-catenin signaling pathway.
    Exp Mol Med. 2018;50:e429.
    Abstract     Related articles   

  91. LI YP, Jia XP, Jiang YQ, Wang W, et al
    Differential expression of cytokeratin 14 and 18 in bladder cancer tumorigenesis.
    Exp Biol Med (Maywood). 2018 Jan 1:1535370218754493.
    Abstract     Related articles   

  92. YANG HJ, Liu GL, Liu B, Liu T, et al
    GP73 promotes invasion and metastasis of bladder cancer by regulating the epithelial-mesenchymal transition through the TGF-beta1/Smad2 signalling pathway.
    J Cell Mol Med. 2018 Jan 19. doi: 10.1111/jcmm.13442.
    Abstract     Related articles   

  93. SINGH R, Mandhani A, Agrawal V, Garg M, et al
    Positive Correlation between Matrix Metalloproteinases and Epithelial-to-Mesenchymal Transition and its Association with Clinical Outcome in Bladder Cancer Patients.
    Cancer Microenviron. 2018 Jan 18. pii: 10.1007/s12307-017-0199.
    Abstract     Related articles   

  94. JI L, Zhong B, Jiang X, Mao F, et al
    Actein induces autophagy and apoptosis in human bladder cancer by potentiating ROS/JNK and inhibiting AKT pathways.
    Oncotarget. 2017;8:112498-112515.
    Abstract     Related articles   

  95. WONG MCS, Fung FDH, Leung C, Cheung WWL, et al
    The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection.
    Sci Rep. 2018;8:1129.
    Abstract     Related articles   

  96. PHELAN A, Lopez-Beltran A, Montironi R, Zhang S, et al
    Inherited forms of bladder cancer: a review of lynch syndrome and other inherited conditions.
    Future Oncol. 2018 Jan 18. doi: 10.2217/fon-2017-0346.
    Abstract     Related articles   

  97. KITCHEN MO, Bryan RT, Emes RD, Luscombe CJ, et al
    HumanMethylation450K Array-Identified Biomarkers Predict Tumour Recurrence/Progression at Initial Diagnosis of High-risk Non-muscle Invasive Bladder Cancer.
    Biomark Cancer. 2018;10:1179299X17751920.
    Abstract     Related articles   

  98. PATEL SG, Weiner AB, Keegan K, Morgan T, et al
    Oncologic outcomes in patients with nonurothelial bladder cancer.
    Indian J Urol. 2018;34:39-44.
    Abstract     Related articles   

  99. RAYN KN, Hale GR, Grave GP, Agarwal PK, et al
    New therapies in nonmuscle invasive bladder cancer treatment.
    Indian J Urol. 2018;34:11-19.
    Abstract     Related articles   

  100. CHOI JB, Lee EJ, Han KD, Hong SH, et al
    Estimating the impact of body mass index on bladder cancer risk: Stratification by smoking status.
    Sci Rep. 2018;8:947.
    Abstract     Related articles   

  101. MCCONKEY DJ, Choi W
    Subtyping Bladder Cancers: Biology vs Bioinformatics.
    J Natl Cancer Inst. 2018 Jan 12. pii: 4804358. doi: 10.1093.
    Abstract     Related articles   

  102. OGIHARA K, Kikuchi E, Watanabe K, Kufukihara R, et al
    Can urologists introduce the concept of "oligometastasis" for metastatic bladder cancer after total cystectomy?
    Oncotarget. 2017;8:111819-111835.
    Abstract     Related articles   

  103. WANG C, Chen L, Yang Y, Zhang M, et al
    Identification of bladder cancer prognostic biomarkers using an ageing gene-related competitive endogenous RNA network.
    Oncotarget. 2017;8:111742-111753.
    Abstract     Related articles   

  104. XIN Z, Yang Z, Xu J, Li C, et al
    Gene expression profiling and construction of a putative gene regulatory network of bladder cancer tumor-initiating cells.
    Oncotarget. 2017;8:111271-111280.
    Abstract     Related articles   

  105. WEINER AB, Keeter MK, Manjunath A, Meeks JJ, et al
    Discrepancies in staging, treatment, and delays to treatment may explain disparities in bladder cancer outcomes: An update from the National Cancer Data Base (2004-2013).
    Urol Oncol. 2018 Jan 12. pii: S1078-1439(17)30644.
    Abstract     Related articles   

  106. PENG D, Zhang CJ, Gong YQ, Hao H, et al
    Prognostic significance of HALP (hemoglobin, albumin, lymphocyte and platelet) in patients with bladder cancer after radical cystectomy.
    Sci Rep. 2018;8:794.
    Abstract     Related articles   

  107. ZAPALA P, Dybowski B, Poletajew S, Bialek L, et al
    Clinical rationale and safety of restaging transurethral resection in indication-stratified patients with high-risk non-muscle-invasive bladder cancer.
    World J Surg Oncol. 2018;16:6.
    Abstract     Related articles   

  108. MACLENNAN MS, Kok MGM, Soliman L, So A, et al
    Capillary electrophoresis-mass spectrometry for targeted and untargeted analysis of the sub-5kDa urine metabolome of patients with prostate or bladder cancer: A feasibility study.
    J Chromatogr B Analyt Technol Biomed Life Sci. 2018;1074-1075:79-85.
    Abstract     Related articles   

  109. HEINER SM, Viers BR, Rivera ME, Linder BJ, et al
    What is the fate of artificial urinary sphincters among men undergoing repetitive bladder cancer treatment?
    Investig Clin Urol. 2018;59:44-48.
    Abstract     Related articles   

  110. BOLT HM
    Highlight report: Occupational urinary bladder cancer.
    EXCLI J. 2017;16:1319-1320.
    Abstract     Related articles   

  111. ARAUJO JE, Lopez-Fernandez H, Diniz MS, Baltazar PM, et al
    Dithiothreitol-based protein equalization technology to unravel biomarkers for bladder cancer.
    Talanta. 2018;180:36-46.
    Abstract     Related articles   

  112. YANG X, Zhao L, Li M, Yan L, et al
    Lidocaine enhances the effects of chemotherapeutic drugs against bladder cancer.
    Sci Rep. 2018;8:598.
    Abstract     Related articles   

  113. YU SS, Dorff TB, Ballas LK, Sadeghi S, et al
    Immunotherapy in urothelial cancer, part 1: T-cell checkpoint inhibition in advanced or metastatic disease.
    Clin Adv Hematol Oncol. 2017;15:466-477.
    Abstract     Related articles   

  114. CANNIOTO R, Etter JL, Guterman LB, Joseph JM, et al
    The association of lifetime physical inactivity with bladder and renal cancer risk: A hospital-based case-control analysis.
    Cancer Epidemiol. 2017;49:24-29.
    Abstract     Related articles   

  115. QAMAR S, Inam QA, Ashraf S, Khan MS, et al
    Prognostic Value of p53 Expression Intensity in Urothelial Cancers.
    J Coll Physicians Surg Pak. 2017;27:232-236.
    Abstract     Related articles   

  116. CALISKAN S, Sungur M
    Bladder Leiomyoma.
    J Coll Physicians Surg Pak. 2017;27:189-190.
    Abstract     Related articles   

  117. MARIEN A, Rock A, Maadarani KE, Francois C, et al
    Urothelial Tumors and Dual-Band Imaging: A New Concept in Confocal Laser Endomicroscopy.
    J Endourol. 2017;31:538-544.
    Abstract     Related articles   

  118. LE GOUX C, Damotte D, Vacher S, Sibony M, et al
    Correlation between messenger RNA expression and protein expression of immune checkpoint-associated molecules in bladder urothelial carcinoma: A retrospective study.
    Urol Oncol. 2017;35:257-263.
    Abstract     Related articles   

  119. USAWACHINTACHIT M, Isaacson DS, Taguchi K, Tzou DT, et al
    A Prospective Case-Control Study Comparing LithoVue, a Single-Use, Flexible Disposable Ureteroscope, with Flexible, Reusable Fiber-Optic Ureteroscopes.
    J Endourol. 2017;31:468-475.
    Abstract     Related articles   

  120. CASADIO V, Salvi S, Martignano F, Gunelli R, et al
    Cell-Free DNA Integrity Analysis in Urine Samples.
    J Vis Exp. 2017;.
    Abstract     Related articles   

  121. KARABULUT YY, Erdogan S, Sayar H, Ergen A, et al
    Primary malignant melanoma of the urinary bladder: clinical, morphological, and molecular analysis of five cases.
    Melanoma Res. 2016.
    Abstract     Related articles   

  122. MITHANI MH, Khan SA, Khalid SE, Siddique R, et al
    Awareness of risk factors and fallacies associated with urinary bladder cancer in our population: A prospective survey.
    J Pak Med Assoc. 2018;68:55-58.
    Abstract     Related articles   

  123. LI Y, Diao F, Shi S, Li K, et al
    Computed tomography and magnetic resonance imaging evaluation of pelvic lymph node metastasis in bladder cancer.
    Chin J Cancer. 2018;37:3.
    Abstract     Related articles   

  124. MOSCHINI M, Mattei A, Cornelius J, Shariat SF, et al
    Surgical treatment for clinical node-positive bladder cancer patients treated with radical cystectomy without neoadjuvant chemotherapy.
    World J Urol. 2018 Jan 24. pii: 10.1007/s00345-018-2190.
    Abstract     Related articles   

  125. KHANDELWAL M, Anand V, Appunni S, Seth A, et al
    Decitabine augments cytotoxicity of cisplatin and doxorubicin to bladder cancer cells by activating hippo pathway through RASSF1A.
    Mol Cell Biochem. 2018 Jan 24. pii: 10.1007/s11010-018-3278.
    Abstract     Related articles   

  126. BUTT SU, Malik L
    Role of immunotherapy in bladder cancer: past, present and future.
    Cancer Chemother Pharmacol. 2018 Jan 24. pii: 10.1007/s00280-018-3518.
    Abstract     Related articles   

  127. CHU M, Zhang C
    Inhibition of angiogenesis by leflunomide via targeting the soluble ephrin-A1/EphA2 system in bladder cancer.
    Sci Rep. 2018;8:1539.
    Abstract     Related articles   

  128. NIWA N, Matsumoto K, Ide H, Nagata H, et al
    Prognostic Value of Pretreatment Albumin-to-Globulin Ratio in Patients With Non-Muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2018 Jan 4. pii: S1558-7673(18)30001.
    Abstract     Related articles   

  129. GOGALIC S, Sauer U, Doppler S, Preininger C, et al
    Investigating Colorimetric Protein Array Assay Schemes for Detection of Recurrence of Bladder Cancer.
    Biosensors (Basel). 2018;8.
    Abstract     Related articles   

  130. POLETAJEW S, Wolinska E, Wasiutynski A, Dybowski B, et al
    [Immunohistochemical differentiation between muscularis mucosae and muscularis propria for improving the staging of bladder cancer in patients undergoing transurethral resection of bladder tumours].
    Pol J Pathol. 2017;68:218-224.
    Abstract     Related articles   

  131. JURACEK J, Peltanova B, Dolezel J, Fedorko M, et al
    Genome-wide identification of urinary cell-free microRNAs for non-invasive detection of bladder cancer.
    J Cell Mol Med. 2018 Jan 24. doi: 10.1111/jcmm.13487.
    Abstract     Related articles   

  132. CORMICK BPM, Langle Y, Belgorosky D, Vanzulli S, et al
    Flavonoid Silybin improves the response to radiotherapy in invasive bladder cancer.
    J Cell Biochem. 2018 Jan 24. doi: 10.1002/jcb.26693.
    Abstract     Related articles   

  133. SANGUEDOLCE F, Cormio A, Massenio P, Pedicillo MC, et al
    Altered expression of HER-2 and the mismatch repair genes MLH1 and MSH2 predicts the outcome of T1 high-grade bladder cancer.
    J Cancer Res Clin Oncol. 2018 Jan 23. pii: 10.1007/s00432-018-2593.
    Abstract     Related articles   

  134. KIMURA G
    [IV .The Role of Immune Checkpoint Blockade in the Treatment of Bladder Cancer].
    Gan To Kagaku Ryoho. 2018;45:38-43.
    Abstract     Related articles   

  135. MIYAZAKI J
    [III .Current Status of Bladder Preservation Therapy for Muscle Invasive Bladder Cancer].
    Gan To Kagaku Ryoho. 2018;45:33-37.
    Abstract     Related articles   

  136. OZONO S, Furuse H
    [II .Problems of Treatment for Non-Muscle Invasive Bladder Cancer].
    Gan To Kagaku Ryoho. 2018;45:30-32.
    Abstract     Related articles   

  137. ONOZAWA M
    [I .Recent Trends in Bladder Cancer Mortality in Japan].
    Gan To Kagaku Ryoho. 2018;45:26-29.
    Abstract     Related articles   

  138. AKAZA H
    [Genitourinary Tumor Four Questions about Bladder Cancer].
    Gan To Kagaku Ryoho. 2018;45:25.
    Abstract     Related articles   

  139. SANLI O, Lotan Y
    Current approaches for identifying high-risk non-muscle invasive bladder cancer.
    Expert Rev Anticancer Ther. 2018 Jan 23. doi: 10.1080/14737140.2018.1432358.
    Abstract     Related articles   

  140. RODRIGUEZ LOPEZ S, Damas Arroyo F, Perez-Utrilla Perez MA, Lopez Sanchez D, et al
    Metastasis of Ta low-grade bladder cancer into the lung and paraneoplastic syndrome without local invasion: A case report and literature review.
    Urol Case Rep. 2017;17:17-18.
    Abstract     Related articles   

  141. LIN ZR, Wang MY, He SY, Cai ZM, et al
    TACC3 transcriptionally upregulates E2F1 to promote cell growth and confer sensitivity to cisplatin in bladder cancer.
    Cell Death Dis. 2018;9:72.
    Abstract     Related articles   

  142. CHENG W, Fu D, Xu F, Zhang Z, et al
    Unwrapping the genomic characteristics of urothelial bladder cancer and successes with immune checkpoint blockade therapy.
    Oncogenesis. 2018;7:2.
    Abstract     Related articles   

  143. HE W, Zhong G, Jiang N, Wang B, et al
    Long noncoding RNA BLACAT2 promotes bladder cancer-associated lymphangiogenesis and lymphatic metastasis.
    J Clin Invest. 2018 Jan 22. pii: 96218. doi: 10.1172/JCI96218.
    Abstract     Related articles   

  144. BOTELHO MC, Alves H, Richter J
    Halting Schistosoma haematobium - associated bladder cancer.
    Int J Cancer Manag. 2017;10.
    Abstract     Related articles   

  145. BUTTERFIELD A, Gupta S
    Next-generation sequencing in non-muscle-invasive bladder cancer-a step towards personalized medicine for a superficial bladder tumor.
    Transl Androl Urol. 2017;6:1198-1202.
    Abstract     Related articles   

  146. RIETHDORF S, Soave A, Rink M
    The current status and clinical value of circulating tumor cells and circulating cell-free tumor DNA in bladder cancer.
    Transl Androl Urol. 2017;6:1090-1110.
    Abstract     Related articles   

  147. MARI A, D'Andrea D, Abufaraj M, Foerster B, et al
    Genetic determinants for chemo- and radiotherapy resistance in bladder cancer.
    Transl Androl Urol. 2017;6:1081-1089.
    Abstract     Related articles   

  148. WEZEL F, Vallo S, Roghmann F
    Do we have biomarkers to predict response to neoadjuvant and adjuvant chemotherapy and immunotherapy in bladder cancer?
    Transl Androl Urol. 2017;6:1067-1080.
    Abstract     Related articles   

  149. INEICHEN GB, Rothlisberger R, Johner KF, Seiler R, et al
    Different stages in drug development for muscle-invasive bladder cancer.
    Transl Androl Urol. 2017;6:1060-1066.
    Abstract     Related articles   

  150. PRADERE B, Thibault C, Vetterlein MW, Leow JJ, et al
    Peri-operative chemotherapy for muscle-invasive bladder cancer: status-quo in 2017.
    Transl Androl Urol. 2017;6:1049-1059.
    Abstract     Related articles   

  151. PANG KH, Esperto F, Noon AP
    Opportunities of next-generation sequencing in non-muscle invasive bladder cancer outcome prediction.
    Transl Androl Urol. 2017;6:1043-1048.
    Abstract     Related articles   

  152. DUQUESNE I, Weisbach L, Aziz A, Kluth LA, et al
    The contemporary role and impact of urine-based biomarkers in bladder cancer.
    Transl Androl Urol. 2017;6:1031-1042.
    Abstract     Related articles   

  153. RINK M
    The landscape of genetics and biomarkers in bladder cancer.
    Transl Androl Urol. 2017;6:1027-1030.
    Abstract     Related articles   


  154. Erratum to: Hafeez S, McDonald F, Lalondrelle S, et al. Clinical outcomes of image guided adaptive hypofractionated weekly radiation therapy for bladder cancer in patients unsuitable for radical treatment. Int J Radiat Oncol Biol Phys 2017;98:115-122.
    Int J Radiat Oncol Biol Phys. 2018;100:532-533.
    Abstract     Related articles   

  155. OUSATI ASHTIANI Z, Mehrsai AR, Pourmand MR, Pourmand GR, et al
    High Resolution Melting Analysis for Rapid Detection of PIK3CA Gene Mutations in Bladder Cancer: A Mutated Target for Cancer Therapy.
    Urol J. 2018 Jan 21. pii: 3987/1201.
    Abstract     Related articles   

  156. HORVAT N, Ragucci M, Mannelli L
    Hepatic Mass in a Patient With Bladder Cancer History.
    Gastroenterology. 2018 Jan 16. pii: S0016-5085(17)35643.
    Abstract     Related articles   

  157. ZHANG ZF, Zhang HR, Zhang QY, Lai SY, et al
    High expression of TMEM40 is associated with the malignant behavior and tumorigenesis in bladder cancer.
    J Transl Med. 2018;16:9.
    Abstract     Related articles   

  158. BROUGHTON BL, Baron B, Kiernan M, Baack-Kukreja J, et al
    Cystectomy-Enhanced Recovery Program: Nursing Implications.
    Urol Nurs. 2017;37:9-14.
    Abstract     Related articles   

  159. NITTA S, Sakka S, Endo T, Komine M, et al
    [Fever, Hepatic Dysfunction and Interstitial Pneumonia Caused by Intravesical Bacillus Calmette-Guerin (BCG) Instillation after Urethral Bougie : A Case Report].
    Hinyokika Kiyo. 2017;63:427-430.
    Abstract     Related articles   

  160. OZAWA M, Kuromoto A, Morozumi K, Satou M, et al
    [Two Cases of Urachal Carcinoma Treated by TS-1/CDDP as Adjuvant Chemotherapy].
    Hinyokika Kiyo. 2017;63:413-419.
    Abstract     Related articles   

  161. IKEUCHI R, Sunada T, Yoshikawa T, Yoshida T, et al
    [Reactive Arthritis during the Second Course of Intravesical BCG Therapy Requiring Administration of Methotrexate : A Case Report].
    Hinyokika Kiyo. 2017;63:329-332.
    Abstract     Related articles   

  162. MATSUMOTO Y, Waku N, Kawai K, Ikeda A, et al
    [A Case of Primary Schwannoma of the Urinary Bladder].
    Hinyokika Kiyo. 2017;63:323-328.
    Abstract     Related articles   

  163. MINATO A, Fujimoto N, Kubo T
    Squamous Differentiation Predicts Poor Response to Cisplatin-Based Chemotherapy and Unfavorable Prognosis in Urothelial Carcinoma of the Urinary Bladder.
    Clin Genitourin Cancer. 2017;15:e1063-e1067.
    Abstract     Related articles   

  164. LEE CH, Ku JY, Jeong CW, Ku JH, et al
    Predictors for Intravesical Recurrence Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A National Multicenter Analysis.
    Clin Genitourin Cancer. 2017;15:e1055-e1061.
    Abstract     Related articles   

  165. SASAKI K, Wada K, Araki M, Kobayashi Y, et al
    Diagnostic Ureteroscopy for Cases Clinically Suspected of Carcinoma in Situ of the Upper Urinary Tract.
    Acta Med Okayama. 2017;71:227-232.
    Abstract     Related articles   

  166. MATOS J, Mussetto I, Podesta R, Schettini D, et al
    Bladder cancer presenting with acrometastases: a different cause of foot pain.
    Skeletal Radiol. 2018 Feb 1. pii: 10.1007/s00256-018-2888.
    Abstract     Related articles   

  167. TANIMOTO R, Saika T, Ebara S, Kobayashi Y, et al
    Prospective randomized controlled trial of postoperative early intravesical chemotherapy with pirarubicin (THP) for solitary non-muscle invasive bladder cancer comparing single and two-time instillation.
    World J Urol. 2018 Jan 31. pii: 10.1007/s00345-018-2196.
    Abstract     Related articles   

  168. TAN YG, Eu E, Lau Kam On W, Huang HH, et al
    Pretreatment neutrophil-to-lymphocyte ratio predicts worse survival outcomes and advanced tumor staging in patients undergoing radical cystectomy for bladder cancer.
    Asian J Urol. 2017;4:239-246.
    Abstract     Related articles   

  169. YANG C, Yuan W, Yang X, Li P, et al
    Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression.
    Mol Cancer. 2018;17:19.
    Abstract     Related articles   

  170. COMPERAT E, Varinot J, Moroch J, Eymerit-Morin C, et al
    A practical guide to bladder cancer pathology.
    Nat Rev Urol. 2018 Jan 31. pii: nrurol.2018.2. doi: 10.1038/nrurol.2018.
    Abstract     Related articles   

  171. BIZHANI F, Hashemi M, Danesh H, Nouralizadeh A, et al
    Association between single nucleotide polymorphisms in the PI3K/AKT/mTOR pathway and bladder cancer risk in a sample of Iranian population.
    EXCLI J. 2018;17:3-13.
    Abstract     Related articles   

  172. CHRISTENSEN E, Nordentoft I, Vang S, Birkenkamp-Demtroder K, et al
    Optimized targeted sequencing of cell-free plasma DNA from bladder cancer patients.
    Sci Rep. 2018;8:1917.
    Abstract     Related articles   

  173. ORYWAL K, Jelski W, Werel T, Szmitkowski M, et al
    The Activity of Class I-IV Alcohol Dehydrogenase Isoenzymes and Aldehyde Dehydrogenase in Bladder Cancer Cells.
    Cancer Invest. 2018 Jan 30:1-7. doi: 10.1080/07357907.2017.1422511.
    Abstract     Related articles   

  174. BUSS JH, Begnini KR, Bender CB, Pohlmann AR, et al
    Nano-BCG: A Promising Delivery System for Treatment of Human Bladder Cancer.
    Front Pharmacol. 2018;8:977.
    Abstract     Related articles   

  175. SWEENEY SK, Luo Y, O'Donnell MA, Assouline JG, et al
    Peptide-Mediated Targeting Mesoporous Silica Nanoparticles: A Novel Tool for Fighting Bladder Cancer.
    J Biomed Nanotechnol. 2017;13:232-42.
    Abstract     Related articles   

  176. HAN Y, Jin X, Zhou H, Liu B, et al
    Identification of key genes associated with bladder cancer using gene expression profiles.
    Oncol Lett. 2018;15:297-303.
    Abstract     Related articles   

  177. JIANG K, Chen H, Tang K, Guan W, et al
    Puerarin inhibits bladder cancer cell proliferation through the mTOR/p70S6K signaling pathway.
    Oncol Lett. 2018;15:167-174.
    Abstract     Related articles   

  178. COLIN R, Grzebyk M, Wild P, Hedelin G, et al
    Bladder cancer and occupational exposure to metalworking fluid mist: a counter-matched case-control study in French steel-producing factories.
    Occup Environ Med. 2018 Jan 26. pii: oemed-2017-104666.
    Abstract     Related articles   

  179. HANG JF, Pan CC
    Response to: Absence of GNAS and BRAF mutations but presence of KRAS mutation in urachal adenocarcinoma: author reply.
    Pathology. 2017;49:562-563.
    Abstract     Related articles   

  180. REIS H, Niedworok C, Szarvas T
    Response to: Absence of GNAS and BRAF mutations but presence of KRAS mutation in urachal adenocarcinoma.
    Pathology. 2017;49:561-562.
    Abstract     Related articles   

  181. WINDER M, Vesela R, Aronsson P, Patel B, et al
    Autonomic Receptor-mediated Regulation of Production and Release of Nitric Oxide in Normal and Malignant Human Urothelial Cells.
    Basic Clin Pharmacol Toxicol. 2017;121:257-265.
    Abstract     Related articles   

  182. BELLMUNT J, Kerst JM, Vazquez F, Morales-Barrera R, et al
    A randomized phase II/III study of cabazitaxel versus vinflunine in metastatic or locally advanced transitional cell carcinoma of the urothelium (SECAVIN).
    Ann Oncol. 2017;28:1517-1522.
    Abstract     Related articles   

  183. LI X, Wang W, Zhu G, He W, et al
    Risk factors, follow-up, and treatment of urethral recurrence following radical cystectomy and urinary diversion for bladder cancer: a meta-analysis of 9498 patients.
    Oncotarget. 2017;9:2782-2796.
    Abstract     Related articles   

  184. WACH S, Weigelt K, Michalke B, Lieb V, et al
    Diagnostic potential of major and trace elements in the serum of bladder cancer patients.
    J Trace Elem Med Biol. 2018;46:150-155.
    Abstract     Related articles   

  185. CATTRINI C, Boccardo F
    Atezolizumab and bladder cancer: facing a complex disease.
    Lancet. 2018;391:305-306.
    Abstract     Related articles   

  186. WANG W, Li C, Chen Y, Teng L, et al
    Increased expression of GGN promotes tumorigenesis in bladder cancer and is correlated with poor prognosis.
    Gene. 2018 Feb 2. pii: S0378-1119(18)30127-6. doi: 10.1016/j.gene.2018.
    Abstract     Related articles   

  187. JOBCZYK M, Pikala M, Rozanski W, Maniecka-Bryla I, et al
    Years of life lost due to bladder cancer among the inhabitants of Poland in the years 2000 to 2014.
    Cent European J Urol. 2017;70:338-343.
    Abstract     Related articles   

  188. WU K, Tan MY, Jiang JT, Mu XY, et al
    Cisplatin inhibits the progression of bladder cancer by selectively depleting G-MDSCs: A novel chemoimmunomodulating strategy.
    Clin Immunol. 2018 Feb 1. pii: S1521-6616(17)30473.
    Abstract     Related articles   

  189. LIN Y, Wang Y, Wu Q, Jin H, et al
    Association between obesity and bladder cancer recurrence: A meta-analysis.
    Clin Chim Acta. 2018;480:41-46.
    Abstract     Related articles   

  190. MASSARI F, Di Nunno V, Cubelli M, Santoni M, et al
    Immune checkpoint inhibitors for metastatic bladder cancer.
    Cancer Treat Rev. 2018;64:11-20.
    Abstract     Related articles   

  191. XU T, Yin J, Chen S, Zhang D, et al
    Elevated 8-oxo-7,8-dihydro-2'-deoxyguanosine in genome of T24 bladder cancer cells induced by halobenzoquinones.
    J Environ Sci (China). 2018;63:133-139.
    Abstract     Related articles   

  192. ARORA HC, Fascelli M, Zhang JH, Isharwal S, et al
    Kidney, Ureteral, and Bladder Cancer: A Primer for the Internist.
    Med Clin North Am. 2018;102:231-249.
    Abstract     Related articles   

  193. SAYYID RK, Sayyid AK, Klaassen Z, Hersey K, et al
    Replacing surveillance cystoscopy with urinary biomarkers in followup of patients with non-muscle-invasive bladder cancer: Patients' and urologic oncologists' perspectives.
    Can Urol Assoc J. 2018 Feb 6. pii: cuaj.4922. doi: 10.5489/cuaj.4922.
    Abstract     Related articles   

  194. ALIVAND M, Soufi RT, Madani AH, Esmaeili SN, et al
    Histonedeacetylase 1 mRNA has elevated expression in clinical specimen of bladder cancer.
    Bratisl Lek Listy. 2018;119:12-16.
    Abstract     Related articles   

  195. THOMA C
    Bladder cancer: Improving NMIBC risk stratification.
    Nat Rev Urol. 2018 Feb 6. pii: nrurol.2018.13. doi: 10.1038/nrurol.2018.
    Abstract     Related articles   

  196. YANG YL, Li MY, Liu L, Wang L, et al
    Perceived stress and its associated demographic-clinical characteristics and positive expectations among Chinese cervical, kidney, and bladder cancer patients.
    Support Care Cancer. 2018 Feb 5. pii: 10.1007/s00520-018-4081.
    Abstract     Related articles   

  197. LI C, Zeng X, Liu Z, Li F, et al
    BDNF VAL66MET Polymorphism Elevates the Risk of Bladder Cancer via MiRNA-146b in Micro-Vehicles.
    Cell Physiol Biochem. 2018;45:366-377.
    Abstract     Related articles   

  198. AGHAMOHAMMADI D, Gargari RM, Fakhari S, Bilehjani E, et al
    Classic versus Inguinal Approach for Obturator Nerve Block in Transurethral Resection of Bladder Cancer under Spinal Anesthesia: A Randomized Controlled Trial.
    Iran J Med Sci. 2018;43:75-80.
    Abstract     Related articles   

  199. ROH YG, Mun MH, Jeong MS, Kim WT, et al
    Drug resistance of bladder cancer cells through activation of ABCG2 by FOXM1.
    BMB Rep. 2018 Feb 5. pii: 4050.
    Abstract     Related articles   

  200. PRESLER M, Wojtczyk-Miaskowska A, Schlichtholz B, Kaluzny A, et al
    Increased expression of the gene encoding stearoyl-CoA desaturase 1 in human bladder cancer.
    Mol Cell Biochem. 2018 Feb 2. pii: 10.1007/s11010-018-3306.
    Abstract     Related articles   

  201. ADAMIETZ IA
    [Complications instead of improved survival and local freedom from recurrence after early radical cystectomy in muscle-invasive bladder cancer compared to multimodal maintenance therapy].
    Strahlenther Onkol. 2018 Feb 2. pii: 10.1007/s00066-018-1274.
    Abstract     Related articles   

  202. SCHROECK FR, Smith N, Shelton JB
    Implementing risk-aligned bladder cancer surveillance care.
    Urol Oncol. 2018 Jan 26. pii: S1078-1439(17)30645.
    Abstract     Related articles   

  203. GUO CC, Al-Ahmadie HA, Flaig TW, Kamat AM, et al
    Contribution of bladder cancer pathology assessment in planning clinical trials.
    Urol Oncol. 2018 Jan 29. pii: S1078-1439(18)30001.
    Abstract     Related articles   

  204. GODWIN JL, Hoffman-Censits J, Plimack E
    Recent developments in the treatment of advanced bladder cancer.
    Urol Oncol. 2018 Jan 26. pii: S1078-1439(17)30647.
    Abstract     Related articles   

  205. HUPE MC, Vahlensieck W, Ozimek T, Struck JP, et al
    Diarrhea and flatulence are major bowel disorders after radical cystectomy: Results from a cross-sectional study in bladder cancer patients.
    Urol Oncol. 2018 Jan 21. pii: S1078-1439(17)30643.
    Abstract     Related articles   

  206. KLAASSEN Z, Goldberg H, Chandrasekar T, Arora K, et al
    Changing Trends for Suicidal Death in Patients With Bladder Cancer: A 40+ Year Population-level Analysis.
    Clin Genitourin Cancer. 2018 Jan 5. pii: S1558-7673(18)30004.
    Abstract     Related articles   

  207. KILTIE AE, Southby R, LeMonnier K, Binnee J, et al
    High Levels of Patient Satisfaction in Joint Uro-oncology Clinics to Assist Patient Choice in Early Prostate Cancer and Muscle-invasive Bladder Cancer.
    Clin Oncol (R Coll Radiol). 2018 Jan 25. pii: S0936-6555(18)30006.
    Abstract     Related articles   

  208. LIAO G, Chen F, Zhong J, Jiang X, et al
    MicroRNA539 inhibits the proliferation and invasion of bladder cancer cells by regulating IGF1R.
    Mol Med Rep. 2018 Jan 25. doi: 10.3892/mmr.2018.8497.
    Abstract     Related articles   

  209. RUTHERFORD C, Patel MI, Tait MA, Smith DP, et al
    Assessment of content validity for patient-reported outcome measures used in patients with non-muscle invasive bladder cancer: a systematic review.
    Support Care Cancer. 2018 Feb 1. pii: 10.1007/s00520-018-4058.
    Abstract     Related articles   

  210. RAZIK A, Das CJ, Sharma S, Seth A, et al
    Diagnostic performance of diffusion-weighted MR imaging at 3.0 T in predicting muscle invasion in urinary bladder cancer: utility of evaluating the morphology of the reactive tumor stalk.
    Abdom Radiol (NY). 2018 Feb 1. pii: 10.1007/s00261-018-1458.
    Abstract     Related articles   

  211. ASAI S, Miura N, Sawada Y, Noda T, et al
    Silencing of ECHDC1 inhibits growth of gemcitabine-resistant bladder cancer cells.
    Oncol Lett. 2018;15:522-527.
    Abstract     Related articles   

  212. WU H, Wang X, Mo N, Zhang L, et al
    B7-homolog 4 promotes epithelial-mesenchymal transition and invasion of bladder cancer cells via activation of nuclear factor-kappaB.
    Oncol Res. 2018 Feb 1. doi: 10.3727/096504018X15172227703244.
    Abstract     Related articles   

  213. LI H, Liu L, Shi Q, Stemmer A, et al
    Bladder cancer: detection and image quality compared among iShim, RESOLVE, and ss-EPI diffusion-weighted MR imaging with high b value at 3.0 T MRI.
    Medicine (Baltimore). 2017;96:e9292.
    Abstract     Related articles   

  214. QIU X, Cao K, Lin T, Chen W, et al
    Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation.
    Int J Nanomedicine. 2017;12:7365-7374.
    Abstract     Related articles   

  215. FARLEY A, Koshiaris C, Oke J, Ryan R, et al
    Physician Support of Smoking Cessation After Diagnosis of Lung, Bladder, or Upper Aerodigestive Tract Cancer.
    Ann Fam Med. 2017;15:443-450.
    Abstract     Related articles   

  216. HODGSON A, Xu B, Satkunasivam R, Downes MR, et al
    Tumour front inflammation and necrosis are independent prognostic predictors in high-grade urothelial carcinoma of the bladder.
    J Clin Pathol. 2018;71:154-160.
    Abstract     Related articles   

  217. KWON JE, Cho NH, Choi YJ, Lim SD, et al
    Level of mitoses in non-muscle invasive papillary urothelial carcinomas (pTa and pT1) at initial bladder biopsy is a simple and powerful predictor of clinical outcome: a multi-center study in South Korea.
    Diagn Pathol. 2017;12:54.
    Abstract     Related articles   

  218. VIRK RK, Abro S, de Ubago JMM, Pambuccian SE, et al
    The value of the UroVysion(R) FISH assay in the risk-stratification of patients with "atypical urothelial cells" in urinary cytology specimens.
    Diagn Cytopathol. 2017;45:481-500.
    Abstract     Related articles   

  219. GUO H, Xu W, Chen J, Yan L, et al
    Positively charged polypeptide nanogel enhances mucoadhesion and penetrability of 10-hydroxycamptothecin in orthotopic bladder carcinoma.
    J Control Release. 2017;259:136-148.
    Abstract     Related articles   

  220. KIM JK, Cho MC, Ku JH, Paick JS, et al
    Preperitoneal placement of an inflatable penile prosthesis reservoir for postoperative erectile dysfunction after radical cystoprostatectomy with orthotopic neobladder.
    Investig Clin Urol. 2016;57:364-6.
    Abstract     Related articles   

  221. MIJNES J, Veeck J, Gaisa NT, Burghardt E, et al
    Promoter methylation of DNA damage repair (DDR) genes in human tumor entities: RBBP8/CtIP is almost exclusively methylated in bladder cancer.
    Clin Epigenetics. 2018;10:15.
    Abstract     Related articles   

  222. WANG M, Guo C, Wang L, Luo G, et al
    Long noncoding RNA GAS5 promotes bladder cancer cells apoptosis through inhibiting EZH2 transcription.
    Cell Death Dis. 2018;9:238.
    Abstract     Related articles   

  223. SU F, He W, Chen C, Liu M, et al
    The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1.
    Cell Death Dis. 2018;9:233.
    Abstract     Related articles   

  224. HIROBE M, Tanaka T, Shindo T, Ichihara K, et al
    Complications within 90 days after radical cystectomy for bladder cancer: results of a multicenter prospective study in Japan.
    Int J Clin Oncol. 2018 Feb 13. pii: 10.1007/s10147-018-1245.
    Abstract     Related articles   

  225. HUANG XX, Wang RX, Lin Q, Chen W, et al
    Inhibitory effects of 2-methoxyestradiol on cell growth and invasion in human bladder cancer T-24 cells.
    Pharmazie. 2017;72:87-90.
    Abstract     Related articles   

  226. ZHOU YM, Feng X, Zhou BC, Fan YF, et al
    Evaluation of therapeutic effects of (125)I particles brachytherapy for recurrent bladder cancer.
    Oncol Lett. 2018;15:3453-3457.
    Abstract     Related articles   

  227. XIANG X, Huang J, Mo W, Jiang L, et al
    Long non-coding RNA cartilage injury-related promotes malignancy in bladder cancer.
    Oncol Lett. 2018;15:3049-3055.
    Abstract     Related articles   

  228. LI Z, Zhang TB, Jia DH, Sun WQ, et al
    Genipin inhibits the growth of human bladder cancer cells via inactivation of PI3K/Akt signaling.
    Oncol Lett. 2018;15:2619-2624.
    Abstract     Related articles   

  229. MA Z, Xue S, Zeng B, Qiu D, et al
    lncRNA SNHG5 is associated with poor prognosis of bladder cancer and promotes bladder cancer cell proliferation through targeting p27.
    Oncol Lett. 2018;15:1924-1930.
    Abstract     Related articles   

  230. MEMON AA, Gilliver SC, Borre M, Sundquist J, et al
    Soluble HER3 predicts survival in bladder cancer patients.
    Oncol Lett. 2018;15:1783-1788.
    Abstract     Related articles   

  231. KELSEY R
    Bladder cancer: BBN mouse model mimics human MIBC.
    Nat Rev Urol. 2018 Feb 13. pii: nrurol.2018.17. doi: 10.1038/nrurol.2018.
    Abstract     Related articles   

  232. XU M, Li J, Wang X, Meng S, et al
    MiR-22 suppresses epithelial-mesenchymal transition in bladder cancer by inhibiting Snail and MAPK1/Slug/vimentin feedback loop.
    Cell Death Dis. 2018;9:209.
    Abstract     Related articles   

  233. PAQUETTE M, Beaudoin S, Tremblay MA, Jean S, et al
    NLS-cholic acid conjugation to IL-5Ralpha-specific antibody improves cellular accumulation and in vivo tumor-targeting properties in a bladder cancer model.
    Bioconjug Chem. 2018 Feb 13. doi: 10.1021/acs.bioconjchem.8b00077.
    Abstract     Related articles   

  234. MESSING EM
    Molecular Landscape of Non-Muscle Invasive Bladder Cancer.
    Bladder Cancer. 2018;4:131-132.
    Abstract     Related articles   

  235. GARG T, Connors JN, Ladd IG, Bogaczyk TL, et al
    Defining Priorities to Improve Patient Experience in Non-Muscle Invasive Bladder Cancer.
    Bladder Cancer. 2018;4:121-128.
    Abstract     Related articles   

  236. FARBER NJ, Faiena I, Dombrovskiy V, Tabakin AL, et al
    Disparities in the Use of Continent Urinary Diversions after Radical Cystectomy for Bladder Cancer.
    Bladder Cancer. 2018;4:113-120.
    Abstract     Related articles   

  237. WESTHOFF E, Witjes JA, Fleshner NE, Lerner SP, et al
    Body Mass Index, Diet-Related Factors, and Bladder Cancer Prognosis: A Systematic Review and Meta-Analysis.
    Bladder Cancer. 2018;4:91-112.
    Abstract     Related articles   

  238. TAMURA S, Wang Y, Veeneman B, Hovelson D, et al
    Molecular Correlates of In Vitro Responses to Dacomitinib and Afatinib in Bladder Cancer.
    Bladder Cancer. 2018;4:77-90.
    Abstract     Related articles   

  239. WALKER M, Doiron RC, French SD, Brennan K, et al
    Peri-Operative Chemotherapy for Bladder Cancer: A Survey of Providers to Determine Barriers and Enablers.
    Bladder Cancer. 2018;4:49-65.
    Abstract     Related articles   

  240. LI R, Metcalfe M, Kukreja J, Navai N, et al
    Role of Radical Cystectomy in Non-Organ Confined Bladder Cancer: A Systematic Review.
    Bladder Cancer. 2018;4:31-40.
    Abstract     Related articles   

  241. TODENHOFER T, Struss WJ, Seiler R, Wyatt AW, et al
    Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder Cancer.
    Bladder Cancer. 2018;4:19-29.
    Abstract     Related articles   

  242. ABBOSH PH, Plimack ER
    Molecular and Clinical Insights into the Role and Significance of Mutated DNA Repair Genes in Bladder Cancer.
    Bladder Cancer. 2018;4:9-18.
    Abstract     Related articles   

  243. SHERIF A, Winerdal M, Winqvist O
    Immune Responses to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer.
    Bladder Cancer. 2018;4:1-7.
    Abstract     Related articles   

  244. MUKHERJEE N, Svatek RS, Mansour AM
    Role of immunotherapy in bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer.
    Urol Oncol. 2018 Feb 8. pii: S1078-1439(17)30649.
    Abstract     Related articles   

  245. MARCHIONI M, Nazzani S, Preisser F, Bandini M, et al
    Therapeutic strategies for organ-confined and non-organ-confined bladder cancer after radical cystectomy.
    Expert Rev Anticancer Ther. 2018 Feb 15:1-11. doi: 10.1080/14737140.2018.1439744
    Abstract     Related articles   

  246. LI WL, Ji GH, Zhang XZ, Yu HY, et al
    [The influence and mechanisms of purple sweet potato anthocyanins on the growth of bladder cancer BIU87 cell].
    Zhonghua Yi Xue Za Zhi. 2018;98:457-459.
    Abstract     Related articles   

  247. ZHANG S, Wang Y, Bondaruk J, Majewski T, et al
    Detection of Bladder Cancer in Urine Sediments by a Novel Multicolor Fluorescence In Situ Hybridization (Quartet) Test.
    Eur Urol Focus. 2018 Feb 7. pii: S2405-4569(18)30018.
    Abstract     Related articles   

  248. FANG CW, Liao CH, Wu SC, Muo CH, et al
    Association of benign prostatic hyperplasia and subsequent risk of bladder cancer: an Asian population cohort study.
    World J Urol. 2018 Feb 9. pii: 10.1007/s00345-018-2216.
    Abstract     Related articles   

  249. ALLIONE A, Pardini B, Viberti C, Oderda M, et al
    The prognostic value of basal DNA damage level in peripheral blood lymphocytes of patients affected by bladder cancer.
    Urol Oncol. 2018 Feb 6. pii: S1078-1439(18)30006.
    Abstract     Related articles   

  250. RIVERO GUERRA A, Fernandez Aparicio T, Barcelo Bayonas I, Pardo Martinez A, et al
    Outpatient Holmium laser fulguration: A safe procedure for treatment of recurrence of nonmuscle invasive bladder cancer.
    Actas Urol Esp. 2018 Feb 5. pii: S0210-4806(18)30003.
    Abstract     Related articles   

  251. LIU X, Li S, Li Y, Cheng B, et al
    Puerarin inhibits proliferation and induces apoptosis by up-regulation of miR-16 in bladder cancer cell line T24.
    Oncol Res. 2018 Feb 8. doi: 10.3727/096504018X15178736525106.
    Abstract     Related articles   

  252. CORMIO L, Mancini V, Calo B, Selvaggio O, et al
    Asymptomatic solitary bladder plasmocytoma: A case report and literature review.
    Medicine (Baltimore). 2017;96:e9347.
    Abstract     Related articles   

  253. FEDUS T, Ras R, Ksiazek M, Filipowska J, et al
    Primary vaginal squamous cell carcinoma with bladder involvement in uterine prolapsed patient: Case report.
    Medicine (Baltimore). 2017;96:e8993.
    Abstract     Related articles   

  254. EL BOTE H, Atik S, Fares R, Hage E, et al
    [Inverted papilloma of the bladder: a rare benign tumor: a case report].
    Pan Afr Med J. 2017;26:204.
    Abstract     Related articles   

  255. KIM HC, Park HP, Lee J, Jeong MH, et al
    Sevoflurane vs. propofol in post-operative catheter-related bladder discomfort: a prospective randomized study.
    Acta Anaesthesiol Scand. 2017;61:773-780.
    Abstract     Related articles   

  256. MOHANTY BD, Mohanty S, Hussain Y, Padmaraju C, et al
    Management of ischemic coronary disease in patients receiving chemotherapy: an uncharted clinical challenge.
    Future Cardiol. 2017;13:247-257.
    Abstract     Related articles   

  257. MANIG L, Janssen S, Schild SE, Rades D, et al
    A New Prognostic Instrument Specifically Designed for Patients Irradiated for Recurrent Carcinoma of the Bladder.
    In Vivo. 2017;31:435-438.
    Abstract     Related articles   

  258. WU GX, Nelson RA, Kim JY, Raz DJ, et al
    Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
    Clin Lung Cancer. 2017 Mar 2. pii: S1525-7304(17)30050.
    Abstract     Related articles   

  259. DUTTA R, Yoon R, Patel RM, Spradling K, et al
    Clinical Comparison of Conventional and Mobile Endockscope Videocystoscopy Using an Air or Fluid Medium.
    J Endourol. 2017;31:593-597.
    Abstract     Related articles   

  260. KOESTLER DC, Usset J, Christensen BC, Marsit CJ, et al
    DNA Methylation-Derived Neutrophil-to-Lymphocyte Ratio: An Epigenetic Tool to Explore Cancer Inflammation and Outcomes.
    Cancer Epidemiol Biomarkers Prev. 2017;26:328-338.
    Abstract     Related articles   

  261. FREMEREY J, Balzer S, Brozou T, Schaper J, et al
    Embryonal rhabdomyosarcoma in a patient with a heterozygous frameshift variant in the DICER1 gene and additional manifestations of the DICER1 syndrome.
    Fam Cancer. 2017;16:401-405.
    Abstract     Related articles   

  262. CHEN QN, Wei CC, Wang ZX, Sun M, et al
    Long non-coding RNAs in anti-cancer drug resistance.
    Oncotarget. 2017;8:1925-1936.
    Abstract     Related articles   

  263. SHIBA S, Wakatsuki M, Kato S, Ohno T, et al
    Carbon-ion radiotherapy for locally advanced cervical cancer with bladder invasion.
    J Radiat Res. 2016.
    Abstract     Related articles   

  264. LIN T, Zhao X, Zhao S, Yu H, et al
    O2-generating MnO2 nanoparticles for enhanced photodynamic therapy of bladder cancer by ameliorating hypoxia.
    Theranostics. 2018;8:990-1004.
    Abstract     Related articles   

  265. MAHE M, Dufour F, Neyret-Kahn H, Moreno-Vega A, et al
    An FGFR3/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers.
    EMBO Mol Med. 2018 Feb 20. pii: emmm.201708163. doi: 10.15252/emmm.201708163.
    Abstract     Related articles   

  266. DU Y, Wang L, Wang W, Guo T, et al
    Novel Application of Cell Penetrating R11 Peptide for Diagnosis of Bladder Cancer.
    J Biomed Nanotechnol. 2018;14:161-167.
    Abstract     Related articles   

  267. SUN X, Zhang T, Deng Q, Zhou Q, et al
    Benzidine Induces Epithelial-Mesenchymal Transition of Human Bladder Cancer Cells through Activation of ERK5 Pathway.
    Mol Cells. 2018 Feb 21. pii: molcells.2018.2113.
    Abstract     Related articles   

  268. LIU Z, Ye Y, Li X, Guo S, et al
    The effects of intra-arterial chemotherapy on bladder preservation in patients with T1 stage bladder cancer.
    World J Urol. 2018 Feb 19. pii: 10.1007/s00345-018-2199.
    Abstract     Related articles   

  269. FLETCHER SA, Gild P, Cole AP, Vetterlein MW, et al
    The effect of treatment at minority-serving hospitals on outcomes for bladder cancer.
    Urol Oncol. 2018 Feb 14. pii: S1078-1439(18)30010.
    Abstract     Related articles   

  270. CEYLAN C, Yahsi S, Dogan S, OztUrk E, et al
    Emphasis of FAS/FASL gene polymorphism in patients with non-muscle invasive bladder cancer.
    Ir J Med Sci. 2018 Feb 16. pii: 10.1007/s11845-018-1764.
    Abstract     Related articles   

  271. DECAESTECKER K, Lumen N, Van Camp C, Oosterlinck W, et al
    Single ablative intravesical electromotive mitomycin C administration for small non-muscle-invasive bladder cancer: a prospective study.
    Acta Clin Belg. 2018 Feb 16:1-4. doi: 10.1080/17843286.2018.1440706.
    Abstract     Related articles   

  272. BHANDARI P, Novikova G, Goergen CJ, Irudayaraj J, et al
    Ultrasound beam steering of oxygen nanobubbles for enhanced bladder cancer therapy.
    Sci Rep. 2018;8:3112.
    Abstract     Related articles   

  273. HU C, Liu Y, Lin Y, Liang JK, et al
    Intravenous injections of the oncolytic virus M1 as a novel therapy for muscle-invasive bladder cancer.
    Cell Death Dis. 2018;9:274.
    Abstract     Related articles   

  274. CHEN WS, Townsend JP, Yu JB
    Radiation-Specific Clinical Data Should Be Included in Existing Large-Scale Genomic Datasets.
    Int J Radiat Oncol Biol Phys. 2017;98:8-10.
    Abstract     Related articles   

  275. GERAILY G, Sharafi N, Shirazi A, Esfehani M, et al
    Comparison of beam hardening effect of physical and enhanced dynamic wedges at bladder inhomogeneity using EBT3 film dosimeter.
    J Cancer Res Ther. 2017;13:97-101.
    Abstract     Related articles   

  276. LEWIS S, Murthy V, Mahantshetty U, Shrivastava SK, et al
    Incidental Dose to Pelvic Nodes in Bladder-Only Radiotherapy: Is It Clinically Relevant?
    Technol Cancer Res Treat. 2017;16:382-387.
    Abstract     Related articles   

  277. CHO YM, Hasumura M, Imai T, Takami S, et al
    Horseradish extract promotes urinary bladder carcinogenesis when administered to F344 rats in drinking water.
    J Appl Toxicol. 2017;37:853-862.
    Abstract     Related articles   

  278. BAO Z, Zhang W, Dong D
    A potential prognostic lncRNA signature for predicting survival in patients with bladder urothelial carcinoma.
    Oncotarget. 2017;8:10485-10497.
    Abstract     Related articles   

  279. SOUKUP V, Capoun O, Pesl M, Sobotka R, et al
    Placental Growth Factor in Bladder Cancer Compared to the Diagnostic Accuracy and Prognostic Performance of Vascular Endothelial Growth Factor A.
    Anticancer Res. 2018;38:239-246.
    Abstract     Related articles   

  280. HEERS H, Gut JM, Hegele A, Hofmann R, et al
    Non-invasive Detection of Bladder Tumors Through Volatile Organic Compounds: A Pilot Study with an Electronic Nose.
    Anticancer Res. 2018;38:833-837.
    Abstract     Related articles   

  281. MIYAKE M, Tatsumi Y, Matsumoto H, Nagao K, et al
    Outcomes of subsequent non-muscle invasive bladder cancer treated with intravesical Bacillus Calmette-Guerin after radical nephroureterectomy for upper urinary tract urothelial carcinoma: A propensity matched analysis with primary bladder cancer.
    BJU Int. 2017 Dec 27. doi: 10.1111/bju.14111.
    Abstract     Related articles   

  282. RITCH CR, Balise R, Soodana Prakash N, Alonzo D, et al
    Propensity matched comparative analysis of survival following chemoradiation or radical cystectomy for muscle invasive bladder cancer.
    BJU Int. 2017 Dec 27. doi: 10.1111/bju.14109.
    Abstract     Related articles   

  283. BOSSCHIETER J, van Moorselaar RJA, Vis AN, van Ginkel T, et al
    The Effect of Timing of an Immediate Instillation with Mitomycin C after Transurethral Resection in 941 Non Muscle-invasive Bladder Cancer Patients.
    BJU Int. 2018 Jan 10. doi: 10.1111/bju.14124.
    Abstract     Related articles   

  284. SEISEN T
    Examining the role of centralisation of radical cystectomy for bladder cancer.
    BJU Int. 2018;121:165-167.
    Abstract     Related articles   

  285. SPAHN M, Morlacco A, Boxler S, Joniau S, et al
    Outcome predictors of radical cystectomy in patients with cT4 prostate cancer: A multi-institutional study of 62 patients.
    BJU Int. 2017 Feb 20. doi: 10.1111/bju.13818.
    Abstract     Related articles   

  286. SAKAGUCHI T, Yoshino H, Yonemori M, Miyamoto K, et al
    Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer.
    Br J Cancer. 2018 Feb 13. pii: bjc2017439. doi: 10.1038/bjc.2017.
    Abstract     Related articles   

  287. CHOUDHURY A, Hoskin PJ
    Bladder cancer and the National Cancer Data Base: New insight or misinformation?
    Cancer. 2018 Jan 16. doi: 10.1002/cncr.31210.
    Abstract     Related articles   

  288. DAIZUMOTO K, Yoshimaru T, Matsushita Y, Fukawa T, et al
    A DDX31/mutant-p53/EGFR axis promotes multistep progression of muscle invasive bladder cancer.
    Cancer Res. 2018 Feb 13. pii: 0008-5472.CAN-17-2528.
    Abstract     Related articles   

  289. JIANG G, Huang C, Li J, Huang H, et al
    Transcriptional and Posttranscriptional Upregulation of p27 Mediates Growth Inhibition of Isorhapontigenin (ISO) on Human Bladder Cancer Cells.
    Carcinogenesis. 2018 Feb 2. pii: 4834629. doi: 10.1093.
    Abstract     Related articles   

  290. VAN KESSEL KE, van der Keur KA, Dyrskjot L, Algaba F, et al
    Molecular markers increase precision of the European Association of Urology non-muscle invasive bladder cancer progression risk groups.
    Clin Cancer Res. 2018 Jan 24. pii: 1078-0432.CCR-17-2719.
    Abstract     Related articles   

  291. WANG WJ, Li CF, Chu YY, Wang YH, et al
    Inhibition of the EGFR/STAT3/CEBPD Axis Reverses Cisplatin Cross-resistance with Paclitaxel in the Urothelial Carcinoma of the Urinary Bladder.
    Clin Cancer Res. 2017;23:503-513.
    Abstract     Related articles   

  292. SAITO R, Kobayashi T, Ogawa O
    Re: Comprehensive Molecular Characterization of Muscle-invasive Bladder Cancer.
    Eur Urol. 2017 Dec 20. pii: S0302-2838(17)31042.
    Abstract     Related articles   

  293. PANG KH, Noon AP
    Re: Radical Cystectomy (Bladder Removal) Against Intravesical BCG Immunotherapy for High-risk Non-muscle Invasive Bladder Cancer (BRAVO): A Protocol for a Randomised Controlled Feasibility Study.
    Eur Urol. 2017 Dec 19. pii: S0302-2838(17)31039.
    Abstract     Related articles   

  294. DY GW, Gore JL, Forouzanfar MH, Naghavi M, et al
    Global Burden of Urologic Cancers, 1990-2013.
    Eur Urol. 2017;71:437-446.
    Abstract     Related articles   

  295. COLLINS JW, Hosseini A, Adding C, Nyberg T, et al
    Early Recurrence Patterns Following Totally Intracorporeal Robot-assisted Radical Cystectomy: Results from the EAU Robotic Urology Section (ERUS) Scientific Working Group.
    Eur Urol. 2017;71:723-726.
    Abstract     Related articles   

  296. GAKIS G, Black PC, Bochner BH, Boorjian SA, et al
    Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy.
    Eur Urol. 2017;71:545-557.
    Abstract     Related articles   

  297. BABJUK M, Bohle A, Burger M, Capoun O, et al
    EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
    Eur Urol. 2017;71:447-461.
    Abstract     Related articles   

  298. EL-ACHKAR A, Kassouf W
    Re: Propensity Score Analysis of Radical Cystectomy Versus Bladder-sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic.
    Eur Urol. 2018 Feb 14. pii: S0302-2838(18)30088.
    Abstract     Related articles   

  299. YU Y, Jin H, Xu J, Gu J, et al
    XIAP overexpression promotes bladder cancer invasion in vitro and lung metastasis in vivo via enhancing nucleolin-mediated Rho-GDIbeta mRNA stability.
    Int J Cancer. 2017 Dec 18. doi: 10.1002/ijc.31223.
    Abstract     Related articles   

  300. LIU X, Cheng X, Liu X, He L, et al
    Investigation of the urinary metabolic variations and the application in bladder cancer biomarker discovery.
    Int J Cancer. 2018 Feb 16. doi: 10.1002/ijc.31323.
    Abstract     Related articles   

  301. FUJII Y
    Prediction models for progression of non-muscle-invasive bladder cancer: A review.
    Int J Urol. 2017 Dec 16. doi: 10.1111/iju.13509.
    Abstract     Related articles   

  302. CHANG SS
    Re: Increasing Age is Not Associated with Toxicity Leading to Discontinuation of Treatment in Patients with Urothelial Non-Muscle-Invasive Bladder Cancer Randomised to Receive 3 Years of Maintenance bacille Calmette-Guerin: Results from European Organ
    J Urol. 2018;199:26.
    Abstract     Related articles   

  303. CHANG SS
    Re: Challenges in Pathologic Staging of Bladder Cancer: Proposals for Fresh Approaches of Assessing Pathologic Stage in Light of Recent Studies and Observations Pertaining to Bladder Histoanatomic Variances.
    J Urol. 2018;199:25-26.
    Abstract     Related articles   

  304. NIWA N, Kikuchi E, Matsumoto K, Kosaka T, et al
    Purified protein derivative skin test prior to bacillus Calmette-Guerin therapy may have therapeutic impact in patients with non-muscle-invasive bladder cancer.
    J Urol. 2018 Jan 4. pii: S0022-5347(18)30006-5. doi: 10.1016/j.juro.2017.
    Abstract     Related articles   

  305. ZARGAR H, Shah JB, van Rhijn BW, Daneshmand S, et al
    Neoadjuvant dose dense MVAC versus GC in patients with cT3-4aN0M0 bladder cancer treated with radical cystectomy.
    J Urol. 2018 Jan 9. pii: S0022-5347(18)30036-3. doi: 10.1016/j.juro.2017.
    Abstract     Related articles   

  306. ATALA A
    Re: Mg(II)-Catechin Nanoparticles Delivering siRNA Targeting EIF5A2 Inhibit Bladder Cancer Cell Growth In Vitro and In Vivo.
    J Urol. 2017;198:258-259.
    Abstract     Related articles   

  307. CHANG SS
    Re: Papillary Recurrence of Bladder Cancer at First Evaluation after Induction Bacillus Calmette-Guerin Therapy: Implication for Clinical Trial Design.
    J Urol. 2017;198:255.
    Abstract     Related articles   

  308. CHANG SS
    Re: Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients with Advanced Urothelial Bladder Cancer.
    J Urol. 2018;199:341-342.
    Abstract     Related articles   

  309. CHANG SS
    Re: The Impact of Re-Transurethral Resection on Clinical Outcomes in a Large Multicentre Cohort of Patients with T1 High-Grade/Grade 3 Bladder Cancer Treated with bacille Calmette-Guerin.
    J Urol. 2018;199:340-342.
    Abstract     Related articles   

  310. FANTINI D, Glaser AP, Rimar KJ, Wang Y, et al
    A Carcinogen-induced mouse model recapitulates the molecular alterations of human muscle invasive bladder cancer.
    Oncogene. 2018 Jan 25. pii: 10.1038/s41388-017-0099.
    Abstract     Related articles   

  311. MA J, Ge J, Xue X, Xiu W, et al
    Targeting bladder cancer using activated T cells armed with bispecific antibodies.
    Oncol Rep. 2018 Jan 11. doi: 10.3892/or.2018.6211.
    Abstract     Related articles   

  312. DEHAYNI Y, Tetou M, Khdach Y, Janane A, et al
    [Prognostic of older age for patients with invasive-muscle-bladder cancer and treated by radical cystectomy].
    Prog Urol. 2018 Jan 9. pii: S1166-7087(17)30679.
    Abstract     Related articles   

  313. ZUCCHI A, Costantini E
    "Nested Type" Bladder Cancer: Myth or Reality?
    Urol Int. 2018 Jan 17. pii: 000486533. doi: 10.1159/000486533.
    Abstract     Related articles   

  314. XIA L, Taylor BL, Mamtani R, Christodouleas JP, et al
    Associations between Travel Distance, Hospital Volume, and Outcomes Following Radical Cystectomy in Patients with Muscle-Invasive Bladder Cancer.
    Urology. 2018 Jan 2. pii: S0090-4295(17)31331.
    Abstract     Related articles   

  315. ZHANG Z, Zhang G, Gao Z, Li S, et al
    Comprehensive analysis of differentially expressed genes associated with PLK1 in bladder cancer.
    BMC Cancer. 2017;17:861.
    Abstract     Related articles   

  316. PULIDO M, Roubaud G, Cazeau AL, Mahammedi H, et al
    Safety and efficacy of temsirolimus as second line treatment for patients with recurrent bladder cancer.
    BMC Cancer. 2018;18:194.
    Abstract     Related articles   

  317. SEVERINO PF, Silva M, Carrascal M, Malagolini N, et al
    Oxidative damage and response to Bacillus Calmette-Guerin in bladder cancer cells expressing sialyltransferase ST3GAL1.
    BMC Cancer. 2018;18:198.
    Abstract     Related articles   

  318. HAN S, Kim D, Shivakumar M, Lee YJ, et al
    The effects of alternative splicing on miRNA binding sites in bladder cancer.
    PLoS One. 2018;13:e0190708.
    Abstract     Related articles   

  319. SATHE A, Chalaud G, Oppolzer I, Wong KY, et al
    Parallel PI3K, AKT and mTOR inhibition is required to control feedback loops that limit tumor therapy.
    PLoS One. 2018;13:e0190854.
    Abstract     Related articles   

  320. KIM M, Oh SJ, Kwak C, Kim HH, et al
    Psychometric validation study of the Korean version of the Functional Assessment of Cancer Therapy-Vanderbilt Cystectomy Index.
    PLoS One. 2018;13:e0190570.
    Abstract     Related articles   


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;